Готові списки джерел за темами / Angioplasty

Добірка наукової літератури з теми "Angioplasty"

Автор: Grafiati
Опубліковано: 4 червня 2021
Оновлено: 18 травня 2024

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Angioplasty".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Зміст

  1. Статті в журналах
  2. Дисертації
  3. Книги
  4. Частини книг
  5. Тези доповідей конференцій
  6. Звіти організацій

Статті в журналах з теми "Angioplasty":

1

Vallejo García, Franco Javier, Juan Manuel Senior Sanchez, Andres Fernandez Cadavid, and Arturo Rodriguez Dimuro. "Infarto agudo de miocardio con elevación del ST secundario a oclusión aguda del tronco principal de la coronaria izquierda: reporte de cinco casos." Acta Médica Colombiana 38, no. 2 (June 10, 2013): 83–85. http://dx.doi.org/10.36104/amc.2013.29.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Resumen La oclusión del TPI es poco observada durante la realización de angioplastia primaria en infarto agudo de miocardio, posiblemente en parte por la baja probabilidad de sobrevivir al evento el tiempo suficiente para llegar a un hospital (1). Reportamos cinco casos de pacientes tratados con angioplastia primaria con presentación y evolución clínica diferentes. Palabras clave: Infarto con elevación del ST, angioplastia primaria, oclusión aguda del tronco principal izquierdo. Abstract The left main trunk occlusion is rarely observed during primary angioplasty in acute myocardial infarction, possibly in part by the low probability of surviving the event long enough to reach a hospital. We report five cases of patients treated with primary angioplasty with different clinical presentation and course. Keywords: ST-elevation infarction, primary angioplasty, acute occlusion of the left main trunk.
2

Tranggono Yudo Utomo. "ANGIOPLASTY UNTUK STENOSIS ATEROSKLEROSIS INTRAKRANIAL." Jurnal Kedokteran Universitas Palangka Raya 9, no. 2 (October 28, 2021): 1318–25. http://dx.doi.org/10.37304/jkupr.v9i2.3511.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Stenosis Aterosklerosis Intrakranial (ICAS) adalah penyebab umum Transient Ischemic Attack (TIA) dan stroke iskemik yang merupakan penyebab kematian nomor dua di dunia. Hingga 40 - 50%, tingkat ICAS simptomatik secara signifikan lebih tinggi pada populasi Asia dan mungkin merupakan penyebab paling umum dari stroke di seluruh dunia. Indikasi untuk perawatan endovaskular merupakan tantangan dan pemilihan bahan serta teknik intervensi pada dasarnya berbeda dari pengobatan stenosis ekstrakranial. Prosedur konservatif (perubahan medis dan gaya hidup) dan terapi endovaskular serta pendekatan terapi endovaskular (angioplasti balon perkutan (PTA) atau angioplasti stent-assisted (PTAS)) tersedia untuk perawatan ICAS. Tinjauan pustaka ini bertujuan untuk menevaluasi peran angioplasty sebagai tatalaksana dari stenosis aterosklerosis intrakranial. Perawatan endovaskular, seperti balloon angioplasty dengan atau tanpa stenting, telah muncul sebagai pilihan terapeutik untuk stenosis intrakranial simtomatik. Ada banyak jenis teknik endovaskular yang tersedia untuk perawatan ICAS, termasuk balloon angioplasty, ballon – mounted stent (Pharos Vitesse), dan self – expandable stent (Wingspan), masing-masing memiliki fitur dan keunggulan spesifik yang berkaitan dengan lesi arteri intrakranial yang berbeda. Maka dari itu, terapi endovascular pada pasien ICAS dapat dipertimbangkan sebagai alternatif untuk mencegah TIA/stroke iskemik berulang. Tindakan endovaskular membutuhan pertimbangan yang komprehensif dan persiapan multidisiplin agar dapat memberikan pelayanan yang efektif untuk pasien. Kata Kunci : Stenosis Aterosklerosis Intrakranial, Angioplasty, Aterosklerosis Intrakranial, Stenosis Intrakranial
3

Mohammed, Shaymaa Jalal, and Aso Faeq Salih. "Immediate and Intermediate Outcomes of Balloon Angioplasty in Neonatal Type Coarctation of Aorta in Sulaimani Cardiac Center." Advanced Medical Journal 4, no. 2 (December 1, 2018): 7–11. http://dx.doi.org/10.56056/amj.2018.52.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Background and objectives: Coarctation of aorta is the fourth most prevalent heart disease in infants requiring catheterization and surgery during the first year of life. Unfortunately, the initial clinical manifestations in infants are non-specific and mainly consist of tachypnea, poor feeding, and failure to thrive which result in delays in the correct diagnosis and therapeutic interventions. The aim of the study was to assess the immediate and intermediate outcome of balloon angioplasty in neonatal-type coarctation of aorta. Methods: It is a case series study of 13 young infants with neonatal coarctation of aorta their ages were between 10 days to 18 months and were admitted to intensive care unit of pediatric teaching hospital and Shar Hospital neonatal care unit in Sulaimani. Balloon angioplasty was done for them in Sulaimani cardiac center between February 2014 to October 2017. Results: Balloon angioplasty was done for 13 young infants with good results in 10/13 cases without any complication. There were significant mean pressure gradient changes before and after the procedure (48 ± 18.57mmHg and 28.15 ±16.12mmHg, respectively). The complications of balloon angioplasty were divided into immediate complications which occurred within 24h post angioplastic procedure and included peripheral cyanosis1case (7.7%), small aneurysm formation 1 case(7.7%), and intermediate complications which occurred within 6 month of the angioplasty showed repeated dilatation of coarctation in 1 case (7.7%), while in 10 cases (76.9%) there were no any complications. Conclusions: Balloon angioplasty is a safe and effective treatment option in infants with coarctation of aorta; however, timely diagnosis and improvement in angioplasty techniques are necessary to improve the outcome.
4

De Portu, Simona, Simona Cammarota, Enrica Menditto, and Lorenzo G. Mantovani. "Valutazione economica dello studio AVERT." Farmeconomia. Health economics and therapeutic pathways 8, no. 2S (October 15, 2007): 31–35. http://dx.doi.org/10.7175/fe.v8i2s.1028.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Introduction: the AVERT study (“Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease”) compared aggressive cholesterol-lowering (with the statin atorvastatin) to angioplasty in patients with mild to moderate coronary artery disease. Aim: our aim was to investigate the economic consequence of high dose of atorvastatin vs percutaneous coronary revascularization followed by standard therapy in Italian patients with stable coronary artery disease Methods: clinical information were taken from the AVERT study. We conducted a cost-effectiveness analysis, comparing high dose of atorvastatin (80 mg/die) versus angioplasty in the perspective of the Italian National Health Service. We identified and quantified medical costs: drug costs according to the Italian National Therapeutic Formulary and hospitalizations were quantified based on the Italian National Health Service tariffs (2006). Effects were measured in terms of mortality and morbidity reduction (number of deaths, life years gained and frequency of hospitalizations). We considered an observation period of 18 months. The costs borne after the first 12 months were discounted using an annual rate of 3%. We conducted one and multi-way sensitivity analyses on unit cost and effectiveness. We also conducted a threshold analysis. Results: the cost of atorvastatin therapy or angioplasty over the 18 months period amounted to approximately 779 euro and 5.5 millions euro per 1,000 patients respectively. Atorvastatin was more efficacious compared to angioplasty and the overall cost of care per 1,000 patients over 18 months of follow-up was estimated at 1.8 millions euro in the atorvastatin group and 7.2 millions euro in the angioplasty group, resulting into a cost saving of 5.4 millions euro that is 74,9% of total costs occurred in the angioplasty group. Discussion: this study demonstrates that high does atorvastatin treatment leads to a reduction of direct costs for the National Health System if compared to angioplastic treatment. Atorvastatin therapy is dominant since it is both less costly and more effective than angioplasty. Results of sensitivity analysis showed that atorvastatin therapy remains dominant even in the most unfavourable hypotheses.
5

Ludyga, T., M. Kazibudzki, M. Simka, M. Hartel, M. Świerad, J. Piegza, P. Latacz, L. Sedlak, and M. Tochowicz. "Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe?" Phlebology: The Journal of Venous Disease 25, no. 6 (November 24, 2010): 286–95. http://dx.doi.org/10.1258/phleb.2010.010053.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Objectives The aim of this report is to assess the safety of endovascular treatment for chronic cerebrospinal venous insufficiency (CCSVI). Although balloon angioplasty and stenting seem to be safe procedures, there are currently no data on the treatment of a large group of patients with this vascular pathology. Methods A total of 564 endovascular procedures (balloon angioplasty or, if this procedure failed, stenting) were performed during 344 interventions in 331 CCSVI patients with associated multiple sclerosis. Results Balloon angioplasty alone was performed in 192 cases (55.8%), whereas the stenting of at least one vein was required in the remaining 152 cases (44.2%). There were no major complications (severe bleeding, venous thrombosis, stent migration or injury to the nerves) related to the procedure, except for thrombotic occlusion of the stent in two cases (1.2% of stenting procedures) and surgical opening of femoral vein to remove angioplastic balloon in one case (0.3% of procedures). Minor complications included occasional technical problems (2.4% of procedures): difficulty removing the angioplastic balloon or problems with proper placement of stent, and other medical events (2.1% of procedures): local bleeding from the groin, minor gastrointestinal bleeding or cardiac arrhythmia. Conclusions The procedures appeared to be safe and well tolerated by the patients, regardless of the actual impact of the endovascular treatments for venous pathology on the clinical course of multiple sclerosis, which warrants long-term follow-up.
6

Jang, G. David, and John Root Stone. "Angioplasty." Critical Care Medicine 16, no. 6 (June 1988): 652. http://dx.doi.org/10.1097/00003246-198806000-00027.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Marty, Alan T. "ANGIOPLASTY." Chest 90, no. 2 (August 1986): 27. http://dx.doi.org/10.1016/s0012-3692(16)61466-6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Spotnitz, William D. "Angioplasty." Annals of Thoracic Surgery 42, no. 1 (July 1986): 99. http://dx.doi.org/10.1016/s0003-4975(10)61847-4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Johnston, K. Wayne, and George Johnson. "Angioplasty." Journal of Vascular Surgery 4, no. 6 (December 1986): A1. http://dx.doi.org/10.1016/s0741-5214(86)70002-5.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Gray, Huon. "Angioplasty." International Journal of Cardiology 20, no. 2 (August 1988): 300. http://dx.doi.org/10.1016/0167-5273(88)90283-5.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел
Також вас можуть зацікавити розширені добірки на тему "Angioplasty" для конкретних типів джерел:
Статті в журналах Дисертації Книги

Дисертації з теми "Angioplasty":

1

Gouveia, Viviane de Araújo. "Impacto do metotrexato na reestenose após implante de stent coronariano convencional." Universidade Federal de Pernambuco, 2015. https://repositorio.ufpe.br/handle/123456789/16384.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Submitted by Fabio Sobreira Campos da Costa (fabio.sobreira@ufpe.br) on 2016-04-07T13:45:11Z No. of bitstreams: 3 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) tese_completa_BIBLIOTECA_10_11_2015.pdf: 1137406 bytes, checksum: 99ca45ce4b42d3ca289fb6979849607a (MD5) tese_completa_BIBLIOTECA_10_11_2015.pdf: 1137406 bytes, checksum: 99ca45ce4b42d3ca289fb6979849607a (MD5)
Made available in DSpace on 2016-04-07T13:45:11Z (GMT). No. of bitstreams: 3 license_rdf: 1232 bytes, checksum: 66e71c371cc565284e70f40736c94386 (MD5) tese_completa_BIBLIOTECA_10_11_2015.pdf: 1137406 bytes, checksum: 99ca45ce4b42d3ca289fb6979849607a (MD5) tese_completa_BIBLIOTECA_10_11_2015.pdf: 1137406 bytes, checksum: 99ca45ce4b42d3ca289fb6979849607a (MD5) Previous issue date: 2015-05-26
Introdução: O advento dos stents convencionais e daqueles liberadores de fármacos aboliu o recolhimento elástico provocado pela angioplastia por balão, porém, estes dispositivos apresentaram como consequência a hiperplasia neointimal, que é responsável pela reestenose angiográfica. O metotrexato, antagonista do folato, inibe a fase S do ciclo de mitose celular, reduzindo a produção de citocinas e outros mediadores inflamatórios que podem estar envolvidos na hiperplasia neointimal. Objetivo: Avaliar a segurança do Metotrexato (MTX) em pacientes com Doença Arterial Coronariana submetidos à Intervenção Coronariana Percutânea (ICP) com stents convencionais e o impacto da droga na reestenose clínica e angiográfica. Método: Estudo clínico de fase II aberto, prospectivo, não randomizado, realizado de setembro de 2011 a maio de 2014. Resultados: Foram recrutados 16 pacientes com indicação de implante de stent, sendo que estes tomaram 5 mg de MTX 15 dias antes e 30 após a ICP. Todos os pacientes foram submetidos à nova angiografia coronariana após 9 meses. A artéria coronária descendente anterior apresentou o maior número de lesões 16 (34%). O diâmetro médio dos stents foi de 3,0 ± 0,4 mm e o comprimento médio foi de 18,1 ± 5,9 mm. Não houve complicações relacionadas à ICP. As complicações do MTX foram menores e com prevalência de 18,7%. Nenhum paciente necessitou de interrupção no uso do medicamento e os sintomas desapareceram ao final do tratamento. A reestenose angiográfica foi 6,2% e a clínica foi zero (ausência de sintoma e de isquemia em cintilografia do miocárdio). Conclusão: O MTX foi seguro e gerou a hipótese de possível efeito benéfico na reestenose após implante de stent convencional.
Introduction: Bare metal stents (BMS) and those releasing drug abolished the elastic recoil caused by Plain Old Balloon Angioplasty (POBA), however, these devices showed the consequence of neointimal hyperplasia, which is responsible for angiographic restenosis. The methotrexate, folate antagonist inhibits S phase of mitotic cell cycle by reducing the production of cytokines and the other inflammatory mediators that may be involved in the neointimal hyperplasia. Objective: To evaluate the safety of Methotrexate (MTX) in patients with coronary artery disease undergoing Percutaneous Coronary Intervention (PCI) with BMS and the impact of drugs in clinical and angiographic restenosis. Methods: Clinical phase II open, prospective, nonrandomized, held from September 2011 to May 2014. Results: We recruited 16 patients with stent implantation indication, and these took 5 mg of MTX 15 days before and 30 after PCI. All patients underwent coronary angiography after nine months. The anterior descending coronary artery had the highest number of lesions 16 (34%). The average diameter of the stents was 3.0 ± 0.4 mm and the average length was 18.1 ± 5.9 mm. There were no complications related to PCI. The MTX complications were minor and with a prevalence of 18.7%. No patient required interruption in the use of the drug, and the symptoms disappeared after the treatment. Angiographic restenosis was 6.2% and the clinic was zero (no symptoms and ischemia on myocardial scintigraphy). Conclusion: MTX was safe and led the hypothesis of possible beneficial effect on restenosis after conventional stent implantation.
2

Garramone, Samantha. "Structure-property relationships in angioplasty balloons." Link to electronic thesis, 2001. http://www.wpi.edu/Pubs/ETD/Available/etd-0430101-122300/.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Mattsson, Erney. "On vessel wall responses to balloon dilatation experimental studies in rabbits /." Lund : Dept. of Surgery, Lund University, Malmö General Hospital, 1992. http://catalog.hathitrust.org/api/volumes/oclc/39693815.html.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Smyth, David William. "The haematological determinants of angioplasty restenosis." Thesis, Queen Mary, University of London, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.244764.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Brack, Michael John. "Heparin and restenosis following angioplasty : a study of the effect of subcutaneous heparin on angiographic recurrence following angioplasty." Thesis, University of Leicester, 1994. http://hdl.handle.net/2381/34223.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Restenosis following percutaneous transluminal coronary angioplasty (PTCA) continues to be the major limitation of the procedure with an incidence of 30-50%. The restenotic process is characterised by myointimal hyperplasia, initiated by smooth muscle cell migration and proliferation. Work in animal models of vascular injury suggests that heparin may reduce myointimal hyperplasia and hence restenosis. I therefore evaluated the effects of unfractionated heparin, 12 500 IU, twice daily, for 4 months, on angiographic and clinical restenosis following PTCA. 339 patients were randomised to receive no heparin (n=172) or 12 500 IU of heparin twice daily (n=167), with angiographic follow-up at 4 months. Blinded quantitative angiographic analysis was undertaken to determine the minimal luminal diameter (mid) pre PTCA, post PTCA and at follow-up. 40 patients defaulted, and 39 patients underwent "early" cardiac catheterisation. A total of 260 patients underwent elective cardiac catheter (n=136 in the no heparin group, n=124 in the heparin group). The mean difference between the mld at follow-up and immediately post PTCA was -0.49 mm(0.57) in the no heparin group, and -0.41mm(0.57) in the heparin group. The treatment effect, 0.08mm, was not significant (p=0.22). The restenosis rate in the no heparin group was 48% and 39% in the heparin group (p=0.32). For early and elective patients combined, the mean difference in mld at follow-up and post PTCA was -0.55 mm(0.58) for the no heparin group, and -0.43 mm(0.59) for the heparin group. The overall treatment effect was 0.12mm, (p=0.06), restenosis rate, 51% in the no heparin group and 41% in the heparin group (p=0.09). At elective follow-up 33% of patients in the no heparin group and 32% of the patients in the heparin group complained of angina. Unfractionated heparin at a dose of 12 500IU twice daily for 4 months does not significantly reduce angiographic or clinical restenosis rates following PTCA.
6

Winkler, Bert. "Perkutane transluminale Angioplastie komplexer infrapoplitealer Gefässläsionen bei kritischer chronischer Extremitätenischämie: Restenoserate und klinische Ergebnisse." Doctoral thesis, Universitätsbibliothek Leipzig, 2014. http://nbn-resolving.de/urn:nbn:de:bsz:15-qucosa-150025.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Shehab, Mostafa El-Said Nasr. "The mechanism of balloon angioplasty : an experimental and clinical study of pressure and volume curves using a computerised angioplasty system." Thesis, University of Bristol, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.268836.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Nyamekye, Isaac. "Photodynamic therapy in the management of angioplasty restenosis." Thesis, University of Bristol, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.294129.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Fleenor, Bradley S. "Post-angioplasty restenosis the effects of exercise training /." Diss., Columbia, Mo. : University of Missouri-Columbia, 2008. http://hdl.handle.net/10355/6097.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
Thesis (Ph. D.)--University of Missouri-Columbia, 2008.
The entire dissertation/thesis text is included in the research.pdf file; the official abstract appears in the short.pdf file (which also appears in the research.pdf); a non-technical general description, or public abstract, appears in the public.pdf file. Vita. "August 2008" Includes bibliographical references.
10

Martins, Valéria Marcia. "Angioplastia transluminal percutânea: contribuição ao tratamento da hipertensão arterial renovascular e da nefropatia isquêmica." Universidade de São Paulo, 2004. http://www.teses.usp.br/teses/disponiveis/5/5151/tde-15102014-113147/.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Анотація:
As lesões estenóticas ou oclusivas das artérias renais podem levar à isquemia do parênquima renal com conseqüente hipertensão arterial (hipertensão arterial renovascular) e perda de função renal (nefropatia isquêmica). Estas duas entidades podem ser tratadas por medicamentos, cirurgia ou angioplastia transluminal percutânea. O objetivo deste trabalho foi avaliar o sucesso técnico e funcional da angioplastia em lesões estenóticas ou oclusivas das artérias renais em doentes portadores de hipertensão arterial renovascular e nefropatia isquêmica. Tratamos 131 doentes hipertensos com ou sem alteração da função renal (55 do sexo masculino e 76 feminino), que apresentavam 191 artérias renais comprometidas (148 estenoses e 43 oclusões) e com média de idade de 45,83 ± 17,4 anos (4 a 77 anos). A etiologia da lesão da artéria renal foi a aterosclerose em 65 doentes (49,61%), displasia fibromuscular em 41 (31,29%), arterite de Takayasu em 13 (9,92%) e outras causas em 12 (9,16%). O nível sérico de creatinina era normal em 70 (53,43%) e alterado em 61 (46,58%). O sucesso técnico foi obtido em 93 doentes (70,99%) e em 123 artérias renais (75,46%). O seguimento foi, em média, de quatro anos (2 a 8 anos), sendo que ao final deste período houve redução de 37,80 ± 33,46 mmHg e 28,66 ± 24,74 mmHg nos níveis da PA sistólica e diastólica, respectivamente. Houve cura da hipertensão arterial em nove doentes (11,25%), melhora em 59 (73,75%), permaneceu inalterada em oito (10%) e piorou em quatro (5%). A função renal ficou normal em 36 doentes (45%), melhorou em 11 (13,75%), manteve-se em 26 (32,5%) e piorou em sete (8,75%). Houve recidiva em 14 casos (17,5%), sendo 11 casos (78,57%) tratados com sucesso com nova angioplastia. Conclusão: consideramos que a angioplastia transluminal percutânea pode ser indicada como opção para o tratamento das lesões estenóticas e/ou oclusivas das artérias renais nos doentes com hipertensão renovascular e nefropatia isquêmica
The occlusive and stenotic lesions of the renal arteries can lead to a renal parenchyma ischemia with vascular hypertension resultant (reno vascular hypertension) and loss of renal function (nephropathy ischemic). These two conditions can be treated by medications, surgery or Percutaneous Transluminal Angioplasty (PTA). The objective of this work was assessing the technical and functional success of PTA in stenotic or occlusive lesions of renal arteries in patients having renovascular hypertension and nephropathy ischemic. We treated 131 hypertensive ill people with or without alteration in the renal function (55 males and 76 females) who presented 191 damaged renal arteries (148 stenosis and 43 occlusions) and age range of 45.83+ 17.4 years old (4 to 77 years old). The etiology of the lesion in the renal artery was atherosclerosis in 65 ill people (49.61%), fibro muscular dysplasia in 41 (31.29%), Takayasu\'s disease in 13 (9.92%), and other causes in 12 (9.16%). The plasma creatinine level was normal in 70 (53.43%) and altered in 61 (46.58%). The technical success was obtained in 93 ill people (70.99%) and in 123 renal arteries (75.46%). The follow-up lasted in average for 4 years (2 to 8 years), in which the end of the period there was a decrease of 37.80+33.46 mmHg and 28.66+24.74 mmHg in the systolic and diastolic blood pressure levels respectively. There was a cure of artery hypertension in 9 ill people (11.25%), better results in 59 (73.75%), no alteration in 8 (10%) and worsening in 4 (5%). The plasma creatinine level increased in 10% (SD), although the renal function remained normal in 36 ill people (45%), better in 11 (13.75%), remained the same in 26 (32.5%) and got worse in 7 (8.75%). There was a reoccurrence in 14 cases (17.5%), in which 11 cases (78.57%) were treated successfully with new PTA. Conclusion: it was considered that PTA can be indicated as an option for the treatment of stenotic and occlusive lesions of the renal arteries in ill people with renovascular hypertension and nephropathy ischemic
Більше джерел

Книги з теми "Angioplasty":

1

A, Clark David. Coronary angioplasty. New York, NY: Liss, 1987.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Siegel, Robert J., ed. Ultrasound Angioplasty. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-1243-7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Watson, Timothy J., Paul JL Ong, and James E. Tcheng, eds. Primary Angioplasty. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1114-7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

von Schmilowski, E., and R. H. Swanton. Essential Angioplasty. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781119950547.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Meier, Bernhard. Coronary angioplasty. Orlando: Grune & Stratton, 1987.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

A, Sanborn Timothy, ed. Laser angioplasty. New York: Liss, 1989.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Bernhard, Meier. Coronary angioplasty. Orlando: Grune & Stratton, 1987.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

J, Siegel Robert, ed. Ultrasound angioplasty. Boston: Kluwer Academic Publishers, 1996.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Schmilowski, Eva von. Essential angioplasty. Chichester, West Sussex, UK: Wiley-Blackwell, 2012.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

A, Clark David. Coronary angioplasty. 2nd ed. New York: Wiley-Liss, 1991.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Більше джерел

Частини книг з теми "Angioplasty":

1

Roth, Elliot J. "Angioplasty." In Encyclopedia of Clinical Neuropsychology, 237–38. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_2152.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Abrams, David B., J. Rick Turner, Linda C. Baumann, Alyssa Karel, Susan E. Collins, Katie Witkiewitz, Terry Fulmer, et al. "Angioplasty." In Encyclopedia of Behavioral Medicine, 96. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_100078.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Roth, Elliot J. "Angioplasty." In Encyclopedia of Clinical Neuropsychology, 170. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-0-387-79948-3_2152.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Roth, Elliot J. "Angioplasty." In Encyclopedia of Clinical Neuropsychology, 1–2. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-56782-2_2152-2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Lee, Zhen Vin, and Bashir Hanif. "Historical Perspectives on Management of Acute Myocardial Infarction." In Primary Angioplasty, 1–13. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1114-7_1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Sathananthan, Janarthanan, Timothy J. Watson, Dale Murdoch, Christopher Overgaard, Deborah Lee, Deanna Khoo, and Paul J. L. Ong. "Management of Intracoronary Thrombus." In Primary Angioplasty, 119–35. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1114-7_10.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Hensey, Mark, Janarthanan Sathananthan, Wahyu Purnomo Teguh, and Niall Mulvihill. "Is There a Role for Bare-Metal Stents in Current STEMI Care?" In Primary Angioplasty, 137–50. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1114-7_11.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Wickramarachchi, Upul, Hee Hwa Ho, and Simon Eccleshall. "Drug-Coated Balloons in STEMI." In Primary Angioplasty, 151–65. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1114-7_12.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Paradies, Valeria, and Pieter C. Smits. "Culprit-Only Artery Versus Multivessel Disease." In Primary Angioplasty, 167–78. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1114-7_13.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Hau, William K. T., and Bryan P. Y. Yan. "Role of Intravascular Imaging in Primary PCI." In Primary Angioplasty, 179–95. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-13-1114-7_14.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Angioplasty":

1

Siegel, Robert J. "Ultrasonic angioplasty." In Modern Technologies Applied to Medical Practice, edited by Roy F. Potter. SPIE, 1990. http://dx.doi.org/10.1117/12.22363.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Jenkins, Ronald D., and J. Richard Spears. "Management of failed angioplasty with laser balloon angioplasty." In OE/LASE '90, 14-19 Jan., Los Angeles, CA, edited by Abraham Katzir. SPIE, 1990. http://dx.doi.org/10.1117/12.17521.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Walinsky, P., A. Rosen, D. Smith, D. Nardone, A. Martinez-Hernandez, and Z. Kosman. "Microwave Balloon Angioplasty." In Electro International, 1991. IEEE, 1991. http://dx.doi.org/10.1109/electr.1991.718177.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Santamore, W. P., W. Untereker, and D. Ogilby. "Lasers And Angioplasty." In Electro International, 1991. IEEE, 1991. http://dx.doi.org/10.1109/electr.1991.718178.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Burrell, Christopher J., Richard I. Kitney, Keith Straughan, and Martin T. Rothman. "Angioplasty under ultrasound?" In OE/LASE '90, 14-19 Jan., Los Angeles, CA, edited by Abraham Katzir. SPIE, 1990. http://dx.doi.org/10.1117/12.17579.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Rosen, A., P. Walin, D. Smith, Y. Shi, Z. Kosman, A. Martinez, H. Rosen, et al. "Microwave Balloon Angioplasty." In 19th European Microwave Conference, 1989. IEEE, 1989. http://dx.doi.org/10.1109/euma.1989.334084.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Otto, Wlodzimierz. "Transluminal laser angioplasty." In Lasers in Medicine, edited by Tadeusz Kecik and Wlodzimierz Nowakowski. SPIE, 1996. http://dx.doi.org/10.1117/12.236831.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Tang, Pengbin, Dongjin Huang, Yin Wang, Ruobin Gong, Wen Tang, and Youdong Ding. "Position based balloon angioplasty." In VRCAI '16: The 15th International Conference on Virtual-Reality Continuum and its Applications in Industry. New York, NY, USA: ACM, 2016. http://dx.doi.org/10.1145/3013971.3013996.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Leckrone, Michael. "Advances In Laser Angioplasty." In The Marketplace for Medical Lasers, edited by Morris R. Levitt and Michael Moretti. SPIE, 1988. http://dx.doi.org/10.1117/12.947558.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Azarnoush, H., and B. Boulet. "Angioplasty balloon deployment control." In 2010 American Control Conference (ACC 2010). IEEE, 2010. http://dx.doi.org/10.1109/acc.2010.5530821.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Angioplasty":

1

Zhang, Yong, and Wen-Jun Gou. Comparison of drug-coated balloon angioplasty versus common balloon angioplasty for arteriovenous fistula stenosis: a Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, August 2022. http://dx.doi.org/10.37766/inplasy2022.8.0112.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Pickard, Jeb S., and Joe E. Burton. Flying Waivers for History of Angioplasty and Myocardial Infraction. Fort Belvoir, VA: Defense Technical Information Center, November 1994. http://dx.doi.org/10.21236/ada292505.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Krastev, Plamen, Diana Trendafilova, Filip Abedinov, Iliyan Petrov, Peyo Simeonov, and Hristo Angelov. Drugeluting Stent versus Bare-metal Stent in Saphenous Grafts Angioplasty. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, June 2019. http://dx.doi.org/10.7546/crabs.2019.06.16.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Knapp, F. F., and D. W. Pipes. Use of Reactor-Produced Radioisotopes for Prevention Restenosis After Angioplasty. Office of Scientific and Technical Information (OSTI), December 1999. http://dx.doi.org/10.2172/760343.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Cutler, David, and Robert Huckman. Technological Development and Medical Productivity: The Diffusion of Angioplasty in New York State. Cambridge, MA: National Bureau of Economic Research, November 2002. http://dx.doi.org/10.3386/w9311.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Jiang, Junhui, and Weiguo Xu. Usefulness and predictability of intravascular ultrasound-guided angioplasty in patients with femoropopliteal lesions: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, June 2021. http://dx.doi.org/10.37766/inplasy2021.6.0080.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Sun, Xiaolei, Junbing Pan, Yarong Ma, Yong Liu, Xiaodong Zhang, and Chunxiang Zhang. The effect of hyperlipemia on restenosis after percutaneous transluminal angioplasty or stenting: A meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2023. http://dx.doi.org/10.37766/inplasy2023.7.0058.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Krastev, Plamen, Violeta Groudeva, Filip Abedinov, Peter Nikolov, Hristo Angelov, and Iliyan Petrov. Early versus Late Primary Percutaneous Coronary Angioplasty in Patients with Acute Myocardial Infarction and Single Vessel Coronary Disease - Factors for Overall Patients Survival Rate. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, July 2020. http://dx.doi.org/10.7546/crabs.2020.07.16.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

sun, xiaolei, cheng zhang, and xiaodong zhang. The relationship of hypertension and target lesion restenosis after percutaneous transluminal angioplast. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2023. http://dx.doi.org/10.37766/inplasy2023.7.0035.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

До бібліографії